These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3207022)

  • 21. Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience.
    Nielsen AK; Østergaard JR
    Eur J Paediatr Neurol; 2013 May; 17(3):265-8. PubMed ID: 23177590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.
    Autti T; Raininko R; Vanhanen SL; Santavuori P
    Neuroradiology; 1996 Jul; 38(5):476-82. PubMed ID: 8837098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?
    Albert DV; Yin H; De Los Reyes EC; Vidaurre J
    J Child Neurol; 2016 Nov; 31(13):1475-1482. PubMed ID: 27445018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Females experience a more severe disease course in Batten disease.
    Cialone J; Adams H; Augustine EF; Marshall FJ; Kwon JM; Newhouse N; Vierhile A; Levy E; Dure LS; Rose KR; Ramirez-Montealegre D; de Blieck EA; Mink JW
    J Inherit Metab Dis; 2012 May; 35(3):549-55. PubMed ID: 22167274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avoid diagnostic delay of late infantile and juvenile neuronal ceroid-lipofuscinosis (LINCL, JNCL): a word to pediatricians, neurologists, and ophthalmologists.
    Heim P; Kohlschütter A
    Am J Med Genet; 1995 Jun; 57(2):238. PubMed ID: 7668337
    [No Abstract]   [Full Text] [Related]  

  • 26. Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD).
    Hofman IL; Taschner PE
    Am J Med Genet; 1995 Jun; 57(2):165-7. PubMed ID: 7668323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).
    Ouseph MM; Kleinman ME; Wang QJ
    Ann N Y Acad Sci; 2016 May; 1371(1):55-67. PubMed ID: 26748992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients.
    Nardocci N; Verga ML; Binelli S; Zorzi G; Angelini L; Bugiani O
    Am J Med Genet; 1995 Jun; 57(2):137-41. PubMed ID: 7668317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
    Marshall FJ; de Blieck EA; Mink JW; Dure L; Adams H; Messing S; Rothberg PG; Levy E; McDonough T; DeYoung J; Wang M; Ramirez-Montealegre D; Kwon JM; Pearce DA
    Neurology; 2005 Jul; 65(2):275-9. PubMed ID: 16043799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linkage analysis in juvenile neuronal ceroid lipofuscinosis.
    Haines JL; Yan WL; Boustany RM; Jewell A; Julier C; Breakefield XO; Gusella JF
    Am J Med Genet; 1992 Feb; 42(4):542-5. PubMed ID: 1609835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diagnosis of and carrier screening for the neuronal ceroid lipofuscinoses.
    Zhong NA; Wisniewski KE; Ju W; Moroziewicz DN; Jurkiewicz A; McLendon L; Jenkins EC; Brown WT
    Genet Test; 2000; 4(3):243-8. PubMed ID: 11142754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal ceroid lipofuscinoses: a clinical and morphological study of 17 patients from southern Brazil.
    Puga AC; Jardim LB; Chimelli L; De Souza CF; Clivati M
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):597-606. PubMed ID: 10973097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis.
    Lauronen L; Munroe PB; Järvelä I; Autti T; Mitchison HM; O'Rawe AM; Gardiner RM; Mole SE; Puranen J; Häkkinen AM; Kirveskari E; Santavuori P
    Neurology; 1999 Jan; 52(2):360-5. PubMed ID: 9932957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-associated acute pancreatitis in a child with neuronal ceroid lipofuscinosis.
    Talwar D
    J Child Neurol; 1994 Jan; 9(1):36-7. PubMed ID: 8151078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Batten disease: features to facilitate early diagnosis.
    Collins J; Holder GE; Herbert H; Adams GG
    Br J Ophthalmol; 2006 Sep; 90(9):1119-24. PubMed ID: 16754648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased erythrocyte and platelet phospholipids and fatty acids in juvenile neuronal ceroid-lipofuscinosis (Batten disease).
    Bennett MJ; Galloway JH; Cartwright IJ; Gillis WS; Hosking GP
    Neuropediatrics; 1990 Nov; 21(4):202-5. PubMed ID: 2290481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis.
    Lamminranta S; Aberg LE; Autti T; Moren R; Laine T; Kaukoranta J; Santavuori P
    J Intellect Disabil Res; 2001 Feb; 45(Pt 1):8-17. PubMed ID: 11168772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.